Consistently, the transfection reagents and equipment market has seen diverse technological advancements in equipment as well as reagents to address the necessities of biotechnology and researchers and biopharmaceutical associations. These degrees of progress have incited the change of transfection instruments that are of higher viability. It has similarly realized profitable quantitative and subjective transfection in a broad assortment of cells, including the hard-to-transfect cells. Transfection is process which incorporates the generation of genetically altered cells from nucleic corrosive. The procedure has its application in transformation of scratch off cells, and protein digestion. The types of gear are utilized for examining considers for quality capacity and quality balance.
How Big is The Global Transfection Reagents and Equipment Market?
The Global Transfection Reagents and Equipment Market is expected to be around US$ 2 Billion by 2028 at a CAGR of 7.5% in the given forecast period.
The major driving factors of Global Transfection Reagents and Equipment Market are as follows:
The restraining factors of Global Transfection Reagents and Equipment Market are as follows:
The Global Transfection Reagents and Equipment Market is segmented on the lines of its technology, treatment, application and regional. Based on Product segmentation it covers Reagents and Instruments. On the basis of method segmentation it covers Biochemical, Calcium Phosphate, Lipofection, DEAE-dextran, Dendrimers, Physical, Electroporation, Nucleofection, Others (Genegun, Sonoporation, Magnetofection, and Optoinjection) and Viral. It covers on the basis of application as Biomedical Research, Gene Expression Studies, Cancer Research, Transgenic Model, Protein Production and Therapeutic Delivery. By end user it is segmented as Academic & Research Institutes and Pharmaceutical & Biotechnology Companies. The Global Transfection Reagents and Equipment Market on geographic segmentation covers various regions such as North America, Europe, Asia Pacific, Latin America, Middle East and Africa. Each geographic market is further segmented to provide market revenue for select countries such as the U.S., Canada, U.K. Germany, China, Japan, India, Brazil, and GCC countries.
This report provides:
1) An overview of the global market for Nasal Spray Market and related technologies.
2) Analyses of global market trends, with data from 2021, estimates for 2022 and 2023, and projections of compound annual growth rates (CAGRs) through 2028.
3) Identifications of new market opportunities and targeted promotional plans for Transfection Reagents and Equipment Market
4) Discussion of research and development, and the demand for new products and new applications.
5) Comprehensive company profiles of major players in the industry.
Report scope:
The scope of the report includes a detailed study of global and regional markets on Transfection Reagents and Equipment Market with the reasons given for variations in the growth of the industry in certain regions.
The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global market. Key players profiled in the report include Promega Corporation (U.S.), Hoffmann-La Roche Ltd. (Switzerland), QIAGEN N.V. (Netherlands). Polyplus-transfection SA (France), Mirus Bio LLC (U.S.), and MaxCyte Inc. (U.S.), Bio-Rad Laboratories (U.S.), Thermo Fisher Scientific Inc. (U.S.), Lonza Group (Switzerland), Sigma-Aldrich Corporation (U.S.). Company profile includes assign such as company summary, financial summary, business strategy and planning, SWOT analysis and current developments.
The Top Companies Report is intended to provide our buyers with a snapshot of the industry’s most influential players.
The Global Transfection Reagents and Equipment Market has been segmented as below:
By Product Analysis:
By Method Analysis:
By Application Analysis:
By End User Analysis:
By Regional Analysis:
Reasons to Buy this Report:
1) Obtain the most up to date information available on all Global Transfection Reagents and Equipment Market.
2) Identify growth segments and opportunities in the industry.
3) Facilitate decision making on the basis of strong historic and forecast of Global Transfection Reagents and Equipment Market data.
4) Assess your competitor’s refining portfolio and its evolution.
Customization:
We can offer you custom research reports as per client’s special requirements.
Below are our New Reports :-
1 INTRODUCTION
1.1 Key Take Aways
1.2 Report Description
1.3 Markets Covered
1.4 Stakeholders
1.5 Research Methodology
1.5.1 Market Size
1.5.2 Market Share
1.5.3 Key Data Points From Secondary Sources
1.5.4 Key Data Points From Primary Sources
2 Research Methodology
2.1 Research Methodology Steps
2.2 Secondary and Primary Research Methodology
2.2.1 Secondary Research
2.2.1.1 Key Data From Secondary Sources
2.2.2 Primary Research
2.2.2.1 Key Data From Primary Sources
2.2.2.2 Key Insights From Primary Sources
2.2.2.3 Key Industry Insights
2.3 Market Size Estimation Methodology
2.3.1 Market Forecast Methodology
2.4 Market Data Validation and Triangulation
2.5 Assumptions
3 Executive Summary
3.1 Introduction
3.2 Conclusion
4 Premium Insights
4.1 Global Transfection Technologies Market
4.2 Transfection Technologies Market, By Application & Region
4.3 Geographic Snapshot: Transfection Technologies Market
4.4 Transfection Technologies Market, By Product (2018 vs 2024)
4.5 Transfection Technologies Market, By End User, 2018 vs 2024 (USD Million)
5 Market Overview
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 Technological Advancements in Transfection Technology
5.2.1.1.1 Crispr-Cas9
5.2.1.1.2 Car-T
5.2.1.1.3 Three Dimension (3D) Transfection Technology
5.2.1.2 Global Alliances Among Leading Research Institutes to Trigger Drug Discovery
5.2.1.3 Increase in R&D Spending and Research Activities By Pharmaceutical and Biotech Companies
5.2.1.4 Growing Research Activities in Cell Science
5.2.1.5 Increase in Demand for Synthetic Genes
5.2.1.6 Rising Incidence of Cancer Worldwide
5.2.2 Restraints
5.2.2.1 Selective Effectiveness of Transfection Reagents
5.2.2.2 Home Brew Reagents Restrict Sale of Commercial Kits
5.2.2.3 High Cost of Transfection Reagents
5.2.3 Opportunities
5.2.3.1 Large-Scale Transfections
5.2.3.2 High-Growth Opportunities in Asian Market
5.2.3.2.1 India
5.2.3.2.2 China
5.2.4 Challenges
5.2.4.1 Transfection in Hard-To-Transfect Cells
5.2.4.2 Cytotoxicity in Transfection – A Major Concern
6 Transfection Technologies Market, By Product
6.1 Introduction
6.2 Reagents
6.3 Equipment
7 Transfection Technologies Market, By Method
7.1 Introduction
7.2 Biochemical Methods
7.2.1 Lipofection
7.2.1.1 Advantages
7.2.1.2 Disadvantages
7.2.2 Calcium Phosphate
7.2.2.1 Advantages
7.2.2.2 Disadvantages
7.2.3 Deae-Dextran
7.2.3.1 Advantages
7.2.3.2 Disadvantages
7.2.4 Dendrimers
7.2.4.1 Advantages
7.2.4.2 Disadvantages
7.3 Physical
7.3.1 Electroporation
7.3.1.1 Advantages
7.3.1.2 Disadvantages
7.3.2 Nucleofection
7.3.2.1 Advantages
7.3.2.2 Disadvantages
7.3.3 Other Methods
7.3.3.1 Sonoporation
7.3.3.2 Genegun
7.3.3.2.1 Advantages
7.3.3.2.2 Disadvantages
7.3.3.3 Magnetofection
7.3.3.3.1 Advantages
7.3.3.3.2 Disadvantages
7.3.3.4 Optoinjection
7.3.3.4.1 Advantages
7.3.3.4.2 Disadvantages
7.4 Viral Methods
7.4.1 Adenoviruses
7.4.2 Retroviruses
7.4.3 Adenoassociated Viruses (AAV)
8 Transfection Technologies Market, By Application
8.1 Introduction
8.2 Biomedical Research
8.2.1 Gene Expression Studies
8.2.2 Cancer Research
8.2.3 Transgenic Models
8.3 Protein Production
8.4 Therapeutic Delivery
9 Transfection Technologies Market, By End User
9.1 Introduction
9.2 Academics & Research Institutes
9.3 Pharmaceutical & Biotechnology Companies
10 Transfection Technologies Market, By Region
10.1 Introduction
10.2 North America
10.2.1 U.S.
10.2.1.1 Increase in Bio-Based Drug Research
10.2.1.2 Growing Demand for Protein-Based Therapeutics Triggers the Growth of U.S. Market
10.2.1.3 Increasing Funding for Biotechnology and for Development of Protein-Based Biologics
10.2.1.4 Conferences/Meetings/Symposiums/Workshops
10.2.2 Canada
10.2.2.1 Government Support for Development of Protein Drugs is Expected to Drive the Market for Transfection Technologies
10.2.2.2 Increasing Investments By the Canadian Government on Regenerative Medicine to Drive Market Growth
10.2.2.3 Increasing Funding for Genome Engineering in Canada Likely to Boost Transfection Technologies Market
10.3 Europe
10.3.1 Germany
10.3.1.1 Growing Biotech Industry and Research Funding in Germany
10.3.1.2 Collaboration Among Bio-Pharmaceutical and Biotechnology Companies for the Development of New Vaccines is Likely to Drive the Market Growth
10.3.1.3 Conferences and Meetings/Workshops in Germany
10.3.1.4 Availability of Funding for Life Science Research in Germany
10.3.2 U.K.
10.3.2.1 10,000 Genome Project Initiative in U.K.
10.3.2.2 Initiative to Increase R&D Investments in U.K.
10.3.3 Rest of Europe
10.3.3.1 Growing Biotechnology and Pharma Industry in Italy
10.3.3.2 Focus on Research in Spain
10.3.3.3 Investments and Funding for Life Sciences to Drive the Transfection Technologies Market
10.3.3.4 Growing Research Investments in Sweden & Denmark
10.4 Asia-Pacific
10.4.1 Japan
10.4.1.1 Rise in Biomedical Research in Japan
10.4.2 China
10.4.2.1 Chinese Government Initiatives for Life Sciences R&D Likely to Boost the Market
10.4.2.2 Industry Initiative to Boost Transfection Technology Market in China
10.4.3 India
10.4.3.1 Booming Pharmaceutical and Biotechnology Industries
10.4.3.2 Development of Bio-Clusters in India
10.4.4 Rest of Asia-Pacific
10.4.4.1 Federal Collaborations in Australia
10.4.4.2 Funding for Research on Proteomics and Genomics in Australia
10.4.4.3 Rising Pharmaceutical and Biotechnology R&D Activities in South Korea
10.4.4.4 Government Support for Strong Academic and Commercial R&D Activities in Taiwan
10.4.4.5 Genome Asia 100k Initative
10.5 Rest of the Word (RoW)
10.5.1 Latin America
10.5.1.1 Increasing Investment in Brazil and Mexico
10.5.1.2 Brazil: Investment in Research and Innovation Centers and Conferences & Workshops
10.5.2 Middle East & Africa
10.5.2.1 Increasing Focus of Major Pharmaceutical, Biopharmaceutical, and Biotechnology Firms in Saudi Arabia and the United Arab Emirates (UAE) and African Regions
10.5.2.2 Genetic Testing and Genomic Analysis in the Middle East
11 Competitive Landscape
11.1 Overview
11.2 Market Share Analysis
11.2.1 Introduction
11.2.2 Thermo Fisher Scientific Inc.
11.2.3 Promega Corporation
11.2.4 F. Hoffmann-La Roche Ltd
11.2.5 Qiagen N.V.
11.3 Competitive Situation and Trends
11.4 Agreements, Collaborations and Partnerships
11.5 New Product Launches
11.6 Expansions
11.7 Acquisitions
11.8 Other Strategies
12 Company Profiles
12.1 Thermo Fisher Scientific Inc. (Life Technologies)
12.2 Promega Corporation
12.3 Qiagen N.V.
12.4 F. Hoffmann-La Roche Ltd
12.5 Bio–Rad Laboratories, Inc.
12.6 Maxcyte, Inc.
12.7 Lonza Group Ltd.
12.8 Merck KGaA
12.9 Polyplus-Transfection Sa (Subsidary of Archimed)
12.10 Mirus Bio LLC.
The Global Transfection Reagents and Equipment Market has been segmented as below:
By Product Analysis:
By Method Analysis:
By Application Analysis:
By End User Analysis:
By Regional Analysis:
SUBSCRIBE TO OUR NEWSLETTERS
